Bio-Scanning Smartphones

The 'Touch-Screen' Cellular Device Tracks Health Through a Camera

With many smartphones offering health-oriented apps and features to track body progress, the conceptual 'Touch-Screen' cellular device opts for a different approach to monitoring by utilizing the phone's existing camera to perform accurate bio-scans. The camera is able to scan the body to perform check-ups and offer health updates via touch screen updates. The innovative design provides touch screens located on both the front and back of the device to detect body changes.

The 'Touch-Screen' is a fittingly named smartphone that utilizes a touch-sensitive screen all over the device -- rather than just on the front. This allows the phone to be used as a sensor for the body while the camera can be used to perform real-time image scans to monitor health.

Bio-scanning Smartphones
Using smartphone cameras to perform accurate bio-scans for health monitoring.
Touch-screen Technology
Utilizing touch-sensitive screens on both the front and back of smartphones for body sensing and detection.
Real-time Health Monitoring
Performing real-time image scans with smartphone cameras to provide health updates and check-ups.

Sectors Adopting This

Healthcare Technology
Opportunity for healthcare technology companies to develop smartphone apps and devices that utilize touch screens and cameras for bio-scanning and health monitoring.
Mobile Device Manufacturing
Disruptive innovation opportunity for mobile device manufacturers to incorporate touch-sensitive screens on the front and back of smartphones to enable bio-sensing capabilities.
Telecommunications
Telecommunications companies can explore partnerships and collaborations with healthcare organizations to provide real-time health monitoring services using smartphone cameras.
SCORE
2.4 out of 10
GENDER
50% Men50% Women
MARKETTop markets: North America
GENERATION
  • Gen Z
  • Gen Alpha
  • Millennial (primary audience)
  • Gen X (primary audience)
POPULARITY
Popularity 27%
Activity 38%
Freshness 8%